Part 2 - Dr. Marty Heslin talks about the "New Normal" for cancer care

TKG PACT Executive Briefings - 3-Minute Market Insights

Innhold levert av The Kinetix Group, Powered by Petauri, The Kinetix Group, and Powered by Petauri. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av The Kinetix Group, Powered by Petauri, The Kinetix Group, and Powered by Petauri eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

3+ y ago 20:25

MP3•Episoder hjem

Send us a text

Part 2 - Dr. Marty Heslin talks about the New Normal for cancer care

Dr. Marty Heslin is the new Cancer Center Director for the University of South Alabama Mitchell Cancer Institute in Mobile, Alabama. He is a Surgical Oncologist, and has spent the last 25 years at the University of Alabama at Birmingham Health System, where he most recently served as the Chief of the Medical Staff, and Executive Vice Chair of Surgery.
In PART 2 of our interview, Dr. Heslin shares his thoughts on how the delivery of cancer care was impacted by the challenges we all faced in 2020. In this episode, Dr. Heslin outlines his thoughts on the critical success factors for cancer centers as we move forward into the “new normal.” He also makes recommendations for how pharmaceutical companies can appropriately align with cancer centers around the shared values of improving patient outcomes.

59 episoder

#Fitness #Medicine #The Kinetix Group #Healthcare #Pharma #Voice #Triple Aim #Biotech #Health Management #Science #Alternative Health #Biology #Insight